Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
Condition:   Vasomotor SymptomsInterventions:   Drug: Estradiol/DRSP (Angeliq, BAY86-4891);   Drug: PlaceboSponsor:   BayerCompleted - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2006 Category: Research Source Type: clinical trials